Overview

Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological Interventional) in Patient with Atrial Fibrillation

Status:
NOT_YET_RECRUITING

Trial end date:
2028-12-22

Target enrollment:

Participant gender:

Summary

Investigator study the efficacy and safety outcomes of Dapagliflozin use among newly diagnosed Atrial fibrillation patients when underwent rhythm control strategy regardless their diabetic status.

Phase:

PHASE1

Details

Lead Sponsor:

Assiut University

Treatments:

dapagliflozin